Fusion gene information | Fusion gene name: HSPB1-WASF1 |
Fusion gene ID: hg3315tg8936 | | Hgene | Tgene | Gene symbol | HSPB1 | WASF1 | Gene ID | 3315 | 8936 | Gene name | heat shock protein family B (small) member 1 | WASP family member 1 |
Synonyms | CMT2F|HEL-S-102|HMN2B|HS.76067|HSP27|HSP28|Hsp25|SRP27 | NEDALVS|SCAR1|WAVE|WAVE1 |
Cytomap | ('HSPB1')('WASF1') 7q11.23 | 6q21 |
Type of gene | protein-coding | protein-coding |
Description | heat shock protein beta-128 kDa heat shock proteinepididymis secretory protein Li 102estrogen-regulated 24 kDa proteinheat shock 27 kDa proteinheat shock 27kD protein 1heat shock 27kDa protein 1stress-responsive protein 27 | wiskott-Aldrich syndrome protein family member 1WAS protein family member 1WASP family protein member 1homology of dictyostelium scar 1protein WAVE-1verprolin homology domain-containing protein 1 |
Modification date | 20200327 | 20200313 |
UniProtAcc | . | . |
Ensembl transtripts involved in fusion gene | ENST00000248553, ENST00000429938,
| |
Fusion gene scores | * DoF score | 24 X 17 X 8=3264 | 7 X 6 X 3=126 |
# samples | 26 | 8 |
** MAII score | log2(26/3264*10)=-3.65005752894304 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(8/126*10)=-0.655351828612554 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 |
Context | PubMed: HSPB1 [Title/Abstract] AND WASF1 [Title/Abstract] AND fusion [Title/Abstract] |
Most frequent breakpoint | HSPB1(75933535)-WASF1(110423249), # samples:1
|
Anticipated loss of major functional domain due to fusion event. | |
Hgene | Tgene |
. | . |
FUNCTION: Transcriptional activator which is required for calcium-dependent dendritic growth and branching in cortical neurons. Recruits CREB-binding protein (CREBBP) to nuclear bodies. Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating a calcium-dependent release of a repressor complex and a recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves a release of HDAC1 and recruitment of CREBBP (By similarity). {ECO:0000250}. | FUNCTION: Transcriptional activator which is required for calcium-dependent dendritic growth and branching in cortical neurons. Recruits CREB-binding protein (CREBBP) to nuclear bodies. Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating a calcium-dependent release of a repressor complex and a recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves a release of HDAC1 and recruitment of CREBBP (By similarity). {ECO:0000250}. |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | HSPB1 | C2608087 | NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE IIB | 13 | CTD_human;GENOMICS_ENGLAND;UNIPROT |
Hgene | HSPB1 | C1847823 | CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2F | 6 | CTD_human;GENOMICS_ENGLAND;UNIPROT |
Hgene | HSPB1 | C0007102 | Malignant tumor of colon | 1 | CTD_human |
Hgene | HSPB1 | C0007134 | Renal Cell Carcinoma | 1 | CTD_human |
Hgene | HSPB1 | C0007137 | Squamous cell carcinoma | 1 | CTD_human |
Hgene | HSPB1 | C0007194 | Hypertrophic Cardiomyopathy | 1 | CTD_human |
Hgene | HSPB1 | C0009375 | Colonic Neoplasms | 1 | CTD_human |
Hgene | HSPB1 | C0011616 | Contact Dermatitis | 1 | CTD_human |
Hgene | HSPB1 | C0018801 | Heart failure | 1 | CTD_human |
Hgene | HSPB1 | C0018802 | Congestive heart failure | 1 | CTD_human |
Hgene | HSPB1 | C0019693 | HIV Infections | 1 | CTD_human |
Hgene | HSPB1 | C0020507 | Hyperplasia | 1 | CTD_human |
Hgene | HSPB1 | C0023212 | Left-Sided Heart Failure | 1 | CTD_human |
Hgene | HSPB1 | C0023467 | Leukemia, Myelocytic, Acute | 1 | CTD_human |
Hgene | HSPB1 | C0024623 | Malignant neoplasm of stomach | 1 | CTD_human |
Hgene | HSPB1 | C0026640 | Mouth Neoplasms | 1 | CTD_human |
Hgene | HSPB1 | C0026764 | Multiple Myeloma | 1 | CTD_human |
Hgene | HSPB1 | C0026998 | Acute Myeloid Leukemia, M1 | 1 | CTD_human |
Hgene | HSPB1 | C0035126 | Reperfusion Injury | 1 | CTD_human |
Hgene | HSPB1 | C0038220 | Status Epilepticus | 1 | CTD_human |
Hgene | HSPB1 | C0038356 | Stomach Neoplasms | 1 | CTD_human |
Hgene | HSPB1 | C0040411 | Tongue Neoplasms | 1 | CTD_human |
Hgene | HSPB1 | C0152013 | Adenocarcinoma of lung (disorder) | 1 | CTD_human |
Hgene | HSPB1 | C0153349 | Malignant neoplasm of tongue | 1 | CTD_human |
Hgene | HSPB1 | C0153381 | Malignant neoplasm of mouth | 1 | CTD_human |
Hgene | HSPB1 | C0162351 | Contact hypersensitivity | 1 | CTD_human |
Hgene | HSPB1 | C0235527 | Heart Failure, Right-Sided | 1 | CTD_human |
Hgene | HSPB1 | C0270823 | Petit mal status | 1 | CTD_human |
Hgene | HSPB1 | C0279702 | Conventional (Clear Cell) Renal Cell Carcinoma | 1 | CTD_human |
Hgene | HSPB1 | C0311335 | Grand Mal Status Epilepticus | 1 | CTD_human |
Hgene | HSPB1 | C0393734 | Complex Partial Status Epilepticus | 1 | CTD_human |
Hgene | HSPB1 | C0751522 | Status Epilepticus, Subclinical | 1 | CTD_human |
Hgene | HSPB1 | C0751523 | Non-Convulsive Status Epilepticus | 1 | CTD_human |
Hgene | HSPB1 | C0751524 | Simple Partial Status Epilepticus | 1 | CTD_human |
Hgene | HSPB1 | C1266042 | Chromophobe Renal Cell Carcinoma | 1 | CTD_human |
Hgene | HSPB1 | C1266043 | Sarcomatoid Renal Cell Carcinoma | 1 | CTD_human |
Hgene | HSPB1 | C1266044 | Collecting Duct Carcinoma of the Kidney | 1 | CTD_human |
Hgene | HSPB1 | C1306837 | Papillary Renal Cell Carcinoma | 1 | CTD_human |
Hgene | HSPB1 | C1708349 | Hereditary Diffuse Gastric Cancer | 1 | CTD_human |
Hgene | HSPB1 | C1854023 | Spinal muscular atrophy, Jerash type | 1 | ORPHANET |
Hgene | HSPB1 | C1879321 | Acute Myeloid Leukemia (AML-M2) | 1 | CTD_human |
Hgene | HSPB1 | C1959583 | Myocardial Failure | 1 | CTD_human |
Hgene | HSPB1 | C1961112 | Heart Decompensation | 1 | CTD_human |
Hgene | HSPB1 | C2239176 | Liver carcinoma | 1 | CTD_human |
Hgene | HSPB1 | C3711384 | Distal Hereditary Motor Neuropathy, Type II | 1 | ORPHANET |
Hgene | HSPB1 | C4505456 | HIV Coinfection | 1 | CTD_human |
Hgene | HSPB1 | C4551472 | Hypertrophic obstructive cardiomyopathy | 1 | CTD_human |
Tgene | | C3714756 | Intellectual Disability | 1 | GENOMICS_ENGLAND |